Understanding cancer at the molecular level can lead to better treatment options. Caris provides cancer patients and oncologists with reliable, high-quality, comprehensive molecular information to deliver …

With a primary focus on cancer, Caris has built a market-leading portfolio of precision medicine tools that have helped more than half a million cancer patients worldwide.

Caris Life Sciences combines the use of sophisticated tumor profiling technologies with leading edge bioinformatics capabilities to advance precision medicine in ways that only we can.

The Caris Molecular Profiling Report delivers high impact results, including potentially relevant, actionable clinical information, in an easy-to-interpret format.

Caris’ industry-leading laboratories help improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in …

Caris helps improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in tissue or blood, plus …

Caris helps improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in tissue or blood, plus …

Jan 12, 2026 · Caris is leading a molecular revolution and developing the latest generation of advanced precision medicine information solutions across the care continuum for a broad range of conditions.

At Caris, patients are at the center of everything we do. Caris Patient Services and Customer Support Teams are available to help guide you during your cancer journey by providing educational, financial …

Caris Assure® is a liquid biopsy that provides a minimally invasive blood test for comprehensive molecular analysis of tumor biomarkers, guiding personalized cancer therapy.